MyFinsight
Home
About
Contact
ibrx: the income statement
Download
Download image
Net loss
attributable to immunitybio...
-$67,253K
(21.55%↑ Y/Y)
Net loss
attributable to...
-$21K
(8.70%↑ Y/Y)
Net loss
-$67,274K
(21.55%↑ Y/Y)
Income tax benefit
-$35K
Loss before income
taxes and...
-$67,309K
(21.51%↑ Y/Y)
Product And Service
Other
$281K
(84.87%↑ Y/Y)
Product
$31,780K
(433.76%↑ Y/Y)
Total other expense,
net
-$11,679K
(-112.38%↓ Y/Y)
Loss from operations
-$55,630K
(30.68%↑ Y/Y)
Change in fair value of
derivative liabilities
$289K
(-82.09%↓ Y/Y)
Change in fair value of
warrant liabilities
-$14,905K
(52.42%↑ Y/Y)
Total revenue
$32,061K
(425.07%↑ Y/Y)
Interest and investment
income, net
$2,067K
(14.96%↑ Y/Y)
Other (expense)
income, net
-$187K
(-1658.33%↓ Y/Y)
Interest expense
(including amounts with...
$26K
Change in fair value of
related-party convertible...
-$1,169K
Interest expense related
to revenue...
$12,302K
(12.60%↑ Y/Y)
Total operating costs
and expenses
$87,691K
(1.54%↑ Y/Y)
Interest expense
(including amounts with...
$15,256K
Selling, general and
administrative-Related Party
$774K
Selling, general and
administrative-Nonrelated Party
$35,508K
Research and
development-Related Party
$2,571K
Research and
development-Nonrelated Party
$48,661K
Cost of sales
$177K
Back
Back
Income Statement
source: myfinsight.com
ImmunityBio-logo-inverted-svg-svg
ImmunityBio, Inc. (IBRX)
ImmunityBio-logo-inverted-svg-svg
ImmunityBio, Inc. (IBRX)